Blog

New Wrinkle Blocker Dysport Gets FDA Clearance

Posted May 03, 2009 in Injection Treatments

A new Botox competitor from Ipsen and Medicis Pharmaceutical has received FDA approval for treating wrinkles and dystonia. Plastic surgeons and dermatologists may have the drug available for cosmetic use in just 30 – 60 days. Rather than rebranding the drug ‘Reloxin’ as planned, Medicis decided to retain its original European name, Dysport The April […]

Botox Competitor Reloxin Could See FDA Approval This Year

Posted March 19, 2009 in Injection Treatments

A study on the safety of the wrinkle relaxer ‘Reloxin’ was just published in Archives of Facial Plastic Surgery‘s March/April issue. The safety and effectiveness of Reloxin was evaluated for moderate to severe forehead wrinkles or ‘glabeller lines.’ The FDA has not yet approved Reloxin, but spokespersons from Medicis Pharmaceutical say clearance is expected later […]

Schedule a Consultation

(541) 687-8900

244 Country Club Rd
Eugene, OR 97401

Get Directions

We Would Love To Hear From You